In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
C. David Mazer, MD
Prof. Kausik Ray, MBChB, MD, MPhil
Paul Ridker, MD
Manesh R. Patel, MD, FACC, FAHA, FSCAI
